Navigation Links
IRIDEX Announces Commercial Availability of New Adjustable & Intuitive EndoProbe® Device for Eye Surgery
Date:10/11/2010

MOUNTAIN VIEW, Calif., Oct. 11 /PRNewswire/ -- IRIDEX Corporation (Nasdaq: IRIX) today announced commercial availability of a new family of Adjustable & Intuitive EndoProbe laser handpieces for use with the Company's laser platforms in vitreoretinal surgery. The Adjustable & Intuitive Laser Probes speed up treatments by allowing continuous, intuitive adjustment of the fiber optic over a wide range of angles for full coverage of the peripheral retina without requiring removal and reinsertion of the probe from the eye or requiring frequent adjustments of laser power settings. In addition, its innovative design and construction allows surgeons to treat further away from the retina and/or at a lower power setting.

"The introduction of this product under a newly issued U.S. patent reinforces our strategy of building upon our position as the global leader in laser delivery instrumentation and to continue to increase the value of our consumable instrumentation line," said Theodore A. Boutacoff, President and CEO.

"We will continue to focus on introducing new products that differentiates us from our competitors and leverage our existing sales channel to increase our revenues."

This product is protected by U.S. Patent No. 7,766,904, "Adjustable Laser Probe For Use In Vitreoretinal Surgery." This patent applies to a number of consumable medical devices already in the IRIDEX product line, collectively identified and sold as Adjustable and Intuitive EndoProbe® laser handpieces.

About IRIDEX

IRIDEX Corporation was founded in 1989 and is a worldwide leader in developing, manufacturing, and marketing innovative and versatile laser-based medical systems and delivery devices. We provide solutions for multiple specialties, including ophthalmology, dermatology and otolaryngology. We maintain a deep commitment to the success of our customers, wi
'/>"/>

SOURCE IRIDEX Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. IRIDEX Announces Second Quarter 2010 Conference Call and Release Date
2. IRIDEX Granted U.S. Patent for Adjustable Laser Probe for Eye Surgery
3. IRIDEX Announces First Commercial Shipment of New IQ 532(TM) Laser Systems
4. IRIDEX Announces First Quarter 2010 Conference Call and Release Date
5. IRIDEX Reports Fourth Quarter and Full Year 2009 Financial Results
6. IRIDEX Announces Fourth Quarter and Full Year 2009 Conference Call and Release Date
7. Ruediger Naumann-Etienne Appointed to IRIDEX Board of Directors
8. IRIDEX Introduces IQ 532 Dual Port Green Laser System at the American Academy of Ophthalmology
9. IRIDEX Introduces Modular Multi-Wavelength Laser Solution at the American Academy of Ophthalmology
10. IRIDEX Introduces New ENT Laser Delivery Devices at AAO-HNSF Annual Meeting
11. TriReme Medical Announces $17 Million Series D Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2014)... MEETING, Pa. , Dec. 15, 2014 /PRNewswire/ ... announced today it has been added to the ... NASDAQ Biotechnology Index will become effective upon market ... NASDAQ Biotechnology Index is designed to track the ... are classified as either biotechnology or pharmaceutical according ...
(Date:12/15/2014)... -- Colorado and Washington State are not ... Oregon , Alaska , ... the November 2014 elections. Photo - ... The benefits of legalizing cannabis are manifold. There ... increased tax revenue for state and local governments, in addition ...
(Date:12/15/2014)... , Dec. 15, 2014 As medical ... (Structured Product Labeling) markup language standard, content teams have ... and skills to work with the standard. Starting January ... of three webinars on the benefits and the critical ... webinars will be facilitated by Howard Shatz , ...
Breaking Medicine Technology:Inovio Pharmaceuticals Added to NASDAQ Biotechnology Index 2Inovio Pharmaceuticals Added to NASDAQ Biotechnology Index 3Inovio Pharmaceuticals Added to NASDAQ Biotechnology Index 4CannaInsider.com Estimates 200,000 New Jobs in the Cannabis Industry by 2015 2Data Conversion Laboratory Helping Life Sciences Content Producers Understand the Impact and Benefits of Structured Product Labeling 2Data Conversion Laboratory Helping Life Sciences Content Producers Understand the Impact and Benefits of Structured Product Labeling 3
... YORK, April 6, 2011 KellBenx, a biotechnology ... diagnosis (NIPD) of genetic and inherited disorders, announced ... with AdnaGen, a wholly-owned subsidiary of Alere, Inc., ... will have exclusive worldwide rights to commercialize the ...
... 6, 2011 /PRNewswire/ -- Royal Philips ... United States availability of the Ingenia MRI system, ... solution. Previously available in Europe, Canada and Japan, ... U.S. Food and Drug Administration. Driven by Philips ...
Cached Medicine Technology:KellBenx Secures Exclusive Worldwide License With AdnaGen for Commercializing Patented Antibodies 2Philips to Take Orders for the Ingenia MRI System in the United States 2Philips to Take Orders for the Ingenia MRI System in the United States 3
(Date:12/17/2014)... HealthDay Reporter , TUESDAY, Dec. 16, 2014 (HealthDay ... health, but a growing body of evidence shows the ancient ... In fact, the benefits were similar to those of ... Chu, a doctoral candidate at Harvard University,s Health Policy Program ... that people randomly assigned to take yoga classes saw improvements ...
(Date:12/15/2014)... 15, 2014 Cancer researchers have just ... genetic causes of deadly malignant pleural mesothelioma. Surviving Mesothelioma ... their website. Click here to read it now. ... Hawaii Cancer Center, and New York’s Langone Medical Center ... mesothelioma patients in an effort to pinpoint the ...
(Date:12/15/2014)... Beach, FL (PRWEB) December 15, 2014 South ... , knows that holidays can be a daze of hassle, ... slips and falls while decking halls, to burns when making ... of holiday hazards that can happen at any time. To ... pain, MD Now has made a list of helpful and ...
(Date:12/15/2014)... MA (PRWEB) December 15, 2014 ... management solutions, announced today that it has received ... Quality Assurance (NCQA) for its Disease Management (DM) ... pulmonary disease (COPD), coronary heart disease and diabetes. ... from NCQA for Health Dialog’s Disease Management (DM) ...
(Date:12/15/2014)... (PRWEB) December 15, 2014 The increase in ... one of the main factors which is contributing to the ... for the diagnosis and treatment of hearing loss and balance ... of three parts - microphone, speaker and amplifier. The global ... rate of 6.01% during the period from 2014 to 2019. ...
Breaking Medicine News(10 mins):Health News:Yoga May Cut Heart Disease Risk Factors 2Health News:Yoga May Cut Heart Disease Risk Factors 3Health News:New Study Reveals Genetic Mutations That May Trigger Mesothelioma, According to Surviving Mesothelioma 2Health News:MD Now Urgent Care Presents Healthy Holiday Tips 2Health News:MD Now Urgent Care Presents Healthy Holiday Tips 3Health News:Health Dialog Receives NCQA Accreditation for Disease Management Programs 2Health News:Audiological Devices Market 2019 Demand for Esthetic Hearing Aids Drives the Growth, Says a Report at ReportsnReports.com 2Health News:Audiological Devices Market 2019 Demand for Esthetic Hearing Aids Drives the Growth, Says a Report at ReportsnReports.com 3Health News:Audiological Devices Market 2019 Demand for Esthetic Hearing Aids Drives the Growth, Says a Report at ReportsnReports.com 4
... By Steven Reinberg HealthDay Reporter , TUESDAY, June ... progression of type 1 diabetes shows some promise, while another ... of two new studies. The results of both studies ... Association annual meeting in San Diego. Type 1 diabetes ...
... Scientists from The Scripps Research Institute have identified a ... involved in wound-healing and sensory communication. The new ... 28, 2011, shows that in this process skin cells ... temperature-sensing and wound-healing. This alternative, oxygen-independent mode of nitric ...
... 28, 2011 Earl L. Smith III, O.D., dean of ... recently received an award for his work in slowing the ... holds the endowed Greeman-Petty Professor chair, accepted the Donald Korb ... contact lens and cornea section of the American Optometric Association ...
... (HealthDay News) -- Many members of low-income families are not ... In assessing the families, eating patterns and the nutritional ... 70 percent of the 100 families, who were newly enrolled ... amounts of several vital nutrients, including vitamins A and C, ...
... same cells that make insulin in the pancreas prevented and ... Michael,s Hospital have found. Type 1 diabetes, formerly known ... of the beta cells in the pancreas that make and ... no insulin. The only conventional treatment for Type ...
... come up with new insight into the brain processes that ... on the "X" in the center of the image in ... (Rocky, the mascot of the University of Rochester) appears to ... We simply think he is growing because our brains have ...
Cached Medicine News:Health News:Trials of Type 1 Diabetes Vaccines Bring Mixed Results 2Health News:Trials of Type 1 Diabetes Vaccines Bring Mixed Results 3Health News:Scientists discover new molecular pathway involved in wound-healing and temperature sensation 2Health News:Scientists discover new molecular pathway involved in wound-healing and temperature sensation 3Health News:Work to slow progression of nearsightedness in children wins award 2Health News:Low-Income Families Often Miss Out on Proper Nutrition 2Health News:Chemical produced in pancreas prevented and reversed diabetes in mice 2Health News:Neuroscientists find famous optical illusion surprisingly potent 2
The Doro Halo retractor system is designed for all neurosurgical applications where retraction of the brain tissue and an armrest is required....
Molt 9, excellent for subperiosteal tunneling....
Love-Adson periosteal elevator, semi sharp, blade width 3/16" (5 mm), length 6 1/2" (165 mm)....
Iowa University periosteal elevator, blade width 11/16" (17 mm), length 7 1/4" (184 mm)....
Medicine Products: